|
|
|
|
| LEADER |
00887caa a2200277 ir4500 |
| 001 |
NSK01000541160 |
| 003 |
HR-ZaNSK |
| 005 |
20070920063951.0 |
| 008 |
041122s2003 ci ||| ||eng |
| 015 |
|
|
|a HP03-4652
|2 HR
|
| 035 |
|
|
|9 (HR-ZaNSK)542082
|
| 035 |
|
|
|9 (HR-ZaNSK)441122149
|
| 035 |
|
|
|a (HR-ZaNSK)000541160
|
| 040 |
|
|
|a HR-ZaNSK
|b hrv
|c HR-ZaNSK
|e ppiak
|
| 041 |
0 |
|
|a eng
|
| 080 |
|
|
|a 615.1
|
| 100 |
1 |
|
|a Pavić-Sladoljev, Dubravka
|
| 245 |
1 |
0 |
|a Including CROs in the process /
|c Dubravka Pavić-Sladoljev.
|
| 300 |
|
|
|b Ilustr.
|
| 500 |
|
|
|a Tema br.: Klinička ispitivanja
|
| 504 |
|
|
|a Bibliografija: 12 jed
|
| 650 |
|
7 |
|a Farmaceutska industrija
|x Razvoj
|2 nskps
|
| 773 |
0 |
|
|t Perspectives (Zagreb. Tisak)
|x 1333-8277
|g 2 (2003), 1 ; str. 28-31
|w nsk.(HR-ZaNSK)000462112
|
| 981 |
|
|
|z B7/03
|
| 998 |
|
|
|a rado0411
|a dimp0411
|c mero050404
|
| 886 |
0 |
|
|2 unimarc
|b 00662naa2 2200217 450
|